Drug Pipeline News

Latest News

FDA gives clearance and CLIA waiver to second generation sexual health test
FDA gives clearance and CLIA waiver to second generation sexual health test

March 21st 2023

Visby Medical has announced its second generation point of care test for detecting sexually transmitted diseases in women has received 510(k) clearance and a CLIA waiver from the FDA.

Adobe Stock/Alesia Kan
Fezolinetant safe, effective for vasomotor symptoms

March 14th 2023

Adobe Stock/ Rattanachat
Covis withdraws Makena from the market

March 9th 2023

Adobe Stock/ Destina
GSK investigational hepatitis therapy will begin phase 3 trials

March 6th 2023

Adobe Stock/ Sherry Young
New Predictors for hepatitis B vaccine response in IBD patients

March 2nd 2023

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.